Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (4) Lusatis, Simone (1) Mathas, Stephan Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (6) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (6) Proteom Dynamik (2) 1992 (4) 1993 (7) (-) 1994 (5) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2001 (5) 2002 (5) 2003 (9) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (3) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (7) 2020 (1) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 8 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 19942006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein 01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein 01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein 01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni 01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein
01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein
01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni
01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert